SLR Is the Second US Hospital to Implant the Innovative INGENIO Pacemaker

Cutting-edge cardiology is taking place at St. Luke’s and Roosevelt Hospitals (SLR). On May 8, Emad Aziz, DO, MB CHB, FACC, a prominent heart specialist, implanted the new INGENIO* pacemaker in Eileen Ford, a 73-year-old Manhattan resident with heart block and chronic obstructive pulmonary disease. The new device, manufactured by Boston Scientific, was approved on May 7 by the Food and Drug Administration. This was the first implant of this pacemaker in the East Coast and the second in the United States.

 “The INGENIO device enables physicians to treat pacemaker patients with an advanced and comprehensive set of therapies,” said Emad Aziz, DO, MB, CHB, FACC, Attending Electrophysiologist, the Department of Medicine and Cardiology at St. Luke’s and Roosevelt Hospitals in New York “using the patient most accurate parameter of breathing; minute ventilation (MV), The INGENIO pacemaker’s MV sensor is easy to optimize and will provide needed therapy for patients with chronotropic incompetence to help them feel less fatigued during physical activity.”

INGENIO pacemakers feature RightRate™ technology.  RightRate utilizes Boston Scientific’s minute ventilation (MV) sensor and adds programming options that promote ease of use and time savings in-clinic.  Boston Scientific’s MV sensor is the only sensor clinically proven to restore chronotropic competence.  Chronotropic Incompetence (CI) is the inability of the heart to regulate its rate appropriately in response to physical activity, which may cause patients to feel tired or short of breath during daily activities such as walking or carrying groceries. CI affects up to 42 percent of pacemaker patients.

The INGENIO pacemaker will also have the capacity to transmit implantable cardiac device data from the device to physicians and other healthcare providers. Boston Scientifics' new LATITUDE NXT® Remote Patient Management system, currently under review by the FDA, will let physicians conduct remote follow-ups of these device patients to monitor specific device information and heart health status.